C07D 497/10
Spiro-condensed systems
C07D497/10 (Spiro-condensed systems) appears on 65 US grants and 75 published applications in this corpus.
Search patents in C07D- Granted patents
- 65
- Published applications
- 75
- Assignees
- 48
- Inventors
- 249
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 2 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 4 |
| 2010 | 3 | 1 |
| 2011 | 4 | 4 |
| 2012 | 0 | 1 |
| 2013 | 3 | 1 |
| 2014 | 2 | 3 |
| 2015 | 0 | 4 |
| 2016 | 2 | 2 |
| 2017 | 4 | 2 |
| 2018 | 1 | 1 |
| 2019 | 1 | 9 |
| 2020 | 3 | 4 |
| 2021 | 6 | 0 |
| 2022 | 7 | 1 |
| 2023 | 0 | 14 |
| 2024 | 5 | 8 |
| 2025 | 3 | 4 |
| 2026 | 5 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Photochromic cyclic compound and curable composition containing the photochromic cyclic compound12 May 2026US 12,624,048 B2Tokuyama Corporation
- Heteroaryl compounds as inhibitors of programmed necrosis pathway, composition and method using the same28 Apr 2026US 12,612,413 B2Accro Bioscience (HK) Limited
- Photochromic compound and curable composition containing the photochromic compound10 Mar 2026US 12,570,894 B2Tokuyama Corporation
- IRAK degraders and uses thereof10 Feb 2026US 12,545,659 B2Kymera Therapeutics, Inc.
- Radiation-sensitive resin composition and method for forming pattern6 Jan 2026US 12,517,429 B2Jsr Corporation
- Photochromic compound, propargyl alcohol compound, curable composition, optical article, lens, and spectacles24 Sep 2026US 2026/0286216 A1Tokuyama Corporation
- Therapeutic alkaloid compounds13 Aug 2026US 2026/0234131 A1Sensorium Therapeutics, Inc.
- Negative allosteric modulators of metabotropic glutamate receptor 26 Aug 2026US 2026/0226019 A1Vanderbilt University
- Delivery of therapeutic alkaloid compounds4 Jun 2026US 2026/0152509 A1Sensorium Therapeutics, Inc.
- Novel dpp1 inhibitors and uses thereof5 Mar 2026US 2026/0062420 A1Insmed Incorporated
Most cited
By later US patents
- Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity82US 5,852,029 AIsrael Institute for Biological Research · 1998
- Spiro compounds containing five-membered rings62US 5,534,520 A1996
- 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors51US 9,637,453 B2FORMA Therapeutics, Inc. · 2017
- 3-spiro-7-hydroxamic acid tetralins as HDAC inhibitors49US 9,630,922 B2FORMA Therapeutics, Inc. · 2017
- Derivatives of mercaptoacyl prolines and pipecolic acids21US 4,311,697 AE. R. Squibb & Sons, Inc. · 1982